Sign In

Login

Password

Forgot Password ? Sign Up

Antidepressivum (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Antidepressivum" in German language version.

refsWebsite
Global rank German rank
29doi.org
2nd place
3rd place
28nih.gov
4th place
7th place
5web.archive.org
1st place
1st place
4zdb-katalog.de
123rd place
6th place
3fda.gov
447th place
751st place
2pharmazeutische-zeitung.de
8,614th place
583rd place
2gelbe-liste.de
low place
2,430th place
1psychiatrie.de
low place
low place
1awmf.org
5,401st place
312th place
1bmj.com
1,226th place
1,116th place
1bewegenvoorjebrein.nl
low place
low place
1redirecter.toolforge.org
33rd place
2nd place
1doccheck.com
9,231st place
597th place
1aerztezeitung.de
low place
711th place
1sanego.de
low place
low place
1gesetze-im-internet.de
1,249th place
80th place
1aerzteblatt.de
3,043rd place
200th place
1biospektrum.de
low place
9,156th place
1bloomberg.com
99th place
323rd place
1compasspathways.com
low place
low place
1spektrum.de
1,960th place
130th place
1researchgate.net
120th place
143rd place

aerzteblatt.de

aerztezeitung.de

awmf.org

bewegenvoorjebrein.nl

  • A. Kandola, G. Ashdown-Franks, J. Hendrikse, C. M. Sabiston, B. Stubbs: Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. In: Neuroscience and biobehavioral reviews. Band 107, Dezember 2019, S. 525–539, doi:10.1016/j.neubiorev.2019.09.040, PMID 31586447 (Review), PDF.

biospektrum.de

  • Roland Seifert, Lutz Hein: Ketamin zur Behandlung von Depression und Suizidalität. In: Biospektrum. Nr. 4, 2015, ISSN 0947-0867, S. 419 (biospektrum.de [PDF; 104 kB; abgerufen am 6. Mai 2023]).

bloomberg.com

bmj.com

bjsm.bmj.com

  • Ben Singh, Timothy Olds, Rachel Curtis, Dorothea Dumuid, Rosa Virgara, Amanda Watson, Kimberley Szeto, Edward O’Connor, Ty Ferguson, Emily Eglitis, Aaron Miatke, Catherine EM Simpson, Carol Maher: Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. In: British Journal of Sports Medicine. 16. Februar 2023, ISSN 0306-3674, doi:10.1136/bjsports-2022-106195, PMID 36796860 (bmj.com [abgerufen am 10. März 2023]).

compasspathways.com

doccheck.com

flexikon.doccheck.com

  • Vortioxetin. DocCheck Medical Services, abgerufen am 14. Juni 2022.

doi.org

  • J. C. Fournier, R. J. DeRubeis, S. D. Hollon, S. Dimidjian, J. D. Amsterdam, R. C. Shelton, J. Fawcett: Antidepressant drug effects and depression severity: a patient-level meta-analysis. In: JAMA. Band 303, Nummer 1, Januar 2010, S. 47–53, doi:10.1001/jama.2009.1943. PMID 20051569, PMC 3712503 (freier Volltext) (Review).
  • P. A. Vöhringer, S. N. Ghaemi: Solving the antidepressant efficacy question: effect sizes in major depressive disorder. In: Clinical therapeutics. Band 33, Nummer 12, Dezember 2011, S. B49–B61, doi:10.1016/j.clinthera.2011.11.019, PMID 22136980, PMC 3242920 (freier Volltext) (Review).
  • D. Santarsieri, T. L. Schwartz: Antidepressant efficacy and side-effect burden: a quick guide for clinicians. In: Drugs in context. Band 4, 2015, S. 212290, doi:10.7573/dic.212290. PMID 26576188, PMC 4630974 (freier Volltext) (Review).
  • F. L. Rocha, C. Fuzikawa, R. Riera, C. Hara: Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. In: Journal of clinical psychopharmacology. Band 32, Nummer 2, April 2012, S. 278–281, doi:10.1097/JCP.0b013e318248581b. PMID 22367652 (Review).
  • C. Björkholm, L. M. Monteggia: BDNF - a key transducer of antidepressant effects. In: Neuropharmacology. [elektronische Veröffentlichung vor dem Druck] November 2015, doi:10.1016/j.neuropharm.2015.10.034. PMID 26519901 (Review).
  • J. S. Lindholm, E. Castrén: Mice with altered BDNF signaling as models for mood disorders and antidepressant effects. In: Frontiers in behavioral neuroscience. Band 8, 2014, S. 143, doi:10.3389/fnbeh.2014.00143. PMID 24817844, PMC 4012208 (freier Volltext) (Review).
  • Ben Singh, Timothy Olds, Rachel Curtis, Dorothea Dumuid, Rosa Virgara, Amanda Watson, Kimberley Szeto, Edward O’Connor, Ty Ferguson, Emily Eglitis, Aaron Miatke, Catherine EM Simpson, Carol Maher: Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. In: British Journal of Sports Medicine. 16. Februar 2023, ISSN 0306-3674, doi:10.1136/bjsports-2022-106195, PMID 36796860 (bmj.com [abgerufen am 10. März 2023]).
  • A. Kandola, G. Ashdown-Franks, J. Hendrikse, C. M. Sabiston, B. Stubbs: Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. In: Neuroscience and biobehavioral reviews. Band 107, Dezember 2019, S. 525–539, doi:10.1016/j.neubiorev.2019.09.040, PMID 31586447 (Review), PDF.
  • C. R. Sharpe, J. P. Collet, E. Belzile, J. A. Hanley, J. F. Boivin: The effects of tricyclic antidepressants on breast cancer risk. In: British Journal of Cancer. Band 86, Nummer 1, Januar 2002, S. 92–97, doi:10.1038/sj.bjc.6600013. PMID 11857018, PMC 2746543 (freier Volltext).
  • Y. Kitaichi, T. Inoue, S. Nakagawa, S. Boku, T. Izumi, T. Koyama: Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine. In: Eur J Pharmacol. 637(1-3), 10. Jul 2010, S. 77 ff., doi:10.1016/j.ejphar.2010.04.014 Epub 2010 Apr 18. PMID 20406628
  • A. C. Nugent, N. Diazgranados, P. J. Carlson, L. Ibrahim, D. A. Luckenbaugh, N. Brutsche, P. Herscovitch, W. C. Drevets, C. A. Zarate: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. In: Bipolar disorders. Band 16, Nummer 2, März 2014, S. 119–128, doi:10.1111/bdi.12118. PMID 24103187, PMC 3949142 (freier Volltext).
  • A. McGirr, M. T. Berlim, D. J. Bond, M. P. Fleck, L. N. Yatham, R. W. Lam: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. In: Psychological medicine. Band 45, Nummer 4, März 2015, S. 693–704, doi:10.1017/S0033291714001603. PMID 25010396 (Review).
  • L. Reinstatler, N. A. Youssef: Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. In: Drugs in R&D. Band 15, Nummer 1, März 2015, S. 37–43, doi:10.1007/s40268-015-0081-0. PMID 25773961, PMC 4359177 (freier Volltext) (Review).
  • D. R. Lara, L. W. Bisol, L. R. Munari: Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. In: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. Band 16, Nummer 9, Oktober 2013, S. 2111–2117, doi:10.1017/S1461145713000485. PMID 23683309.
  • C. M. Coyle, K. R. Laws: The use of ketamine as an antidepressant: a systematic review and meta-analysis. In: Human psychopharmacology. Band 30, Nummer 3, Mai 2015, S. 152–163, doi:10.1002/hup.2475. PMID 25847818 (Review).
  • T. A. Henderson: Practical application of the neuroregenerative properties of ketamine: real world treatment experience. In: Neural regeneration research. Band 11, Nummer 2, Februar 2016, S. 195–200, doi:10.4103/1673-5374.177708, PMID 27073354, PMC 4810965 (freier Volltext) (Review).
  • M. Nielsen, E. H. Hansen, P. C. Gøtzsche: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. In: Addiction. Band 107, Nummer 5, Mai 2012, S. 900–908, doi:10.1111/j.1360-0443.2011.03686.x, PMID 21992148 (Review).
  • G. A. Fava, A. Gatti, C. Belaise, J. Guidi, E. Offidani: Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. In: Psychotherapy and psychosomatics. Band 84, Nummer 2, 2015, S. 72–81, doi:10.1159/000370338, PMID 25721705.
  • G. A. Fava, G. Benasi, M. Lucente, E. Offidani, F. Cosci, J. Guidi: Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review. In: Psychotherapy and psychosomatics. Band 87, Nummer 4, 2018, S. 195–203, doi:10.1159/000491524, PMID 30016772 (Review).
  • J. Davies, J. Read: A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? In: Addictive behaviors. [elektronische Veröffentlichung vor dem Druck] September 2018, doi:10.1016/j.addbeh.2018.08.027, PMID 30292574.
  • D. Rai, B. K. Lee, C. Dalman, J. Golding, G. Lewis, C. Magnusson: Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. In: BMJ. 346, 2013, S. f2059–f2059, doi:10.1136/bmj.f2059.
  • Lisa A. Croen: Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders. In: Archives of General Psychiatry. 68, 2011, S. 1104, doi:10.1001/archgenpsychiatry.2011.73.
  • K. Palmsten, S. Hernandez-Diaz, K. F. Huybrechts, P. L. Williams, K. B. Michels, E. D. Achtyes, H. Mogun, S. Setoguchi: Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. In: BMJ. 347, 2013, S. f4877–f4877, doi:10.1136/bmj.f4877.
  • Yao-Chin Wang, Po-An Tai, Tahmina Nasrin Poly, Md Mohaimenul Islam, Hsuan-Chia Yang: Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies. In: Behavioural Neurology. Band 2018, 2018, doi:10.1155/2018/5315098, PMID 30123386, PMC 6079596 (freier Volltext).
  • John Moraros, Chijioke Nwankwo, Scott B. Patten, Darrell D. Mousseau: The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. In: Depression and Anxiety. Band 34, Nr. 3, März 2017, ISSN 1520-6394, S. 217–226, doi:10.1002/da.22584, PMID 28029715, PMC 5347943 (freier Volltext).
  • Yao-Chin Wang, Po-An Tai, Tahmina Nasrin Poly, Md Mohaimenul Islam, Hsuan-Chia Yang: Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies. In: Behavioural Neurology. Band 2018, 2018, doi:10.1155/2018/5315098, PMID 30123386, PMC 6079596 (freier Volltext).
  • Areeg Bala, Hoang Minh Tue Nguyen, Wayne J. G. Hellstrom: Post-SSRI Sexual Dysfunction: A Literature Review. In: Sexual Medicine Reviews. August 2017, doi:10.1016/j.sxmr.2017.07.002 (englisch, researchgate.net [PDF; 357 kB; abgerufen am 28. Januar 2022]).
  • David Healy, Joanna Le Noury, Derelie Mangin: Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. In: The International Journal of Risk & Safety in Medicine. Band 29, Nr. 3-4, 2018, S. 125, doi:10.3233/JRS-180744, PMID 29733030, PMC 6004900 (freier Volltext).
  • Cipriani, A. et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. DOI:10.1016/S0140-6736(17)32802-7.

fda.gov

fda.gov

accessdata.fda.gov

gelbe-liste.de

gesetze-im-internet.de

nih.gov

ncbi.nlm.nih.gov

  • J. C. Fournier, R. J. DeRubeis, S. D. Hollon, S. Dimidjian, J. D. Amsterdam, R. C. Shelton, J. Fawcett: Antidepressant drug effects and depression severity: a patient-level meta-analysis. In: JAMA. Band 303, Nummer 1, Januar 2010, S. 47–53, doi:10.1001/jama.2009.1943. PMID 20051569, PMC 3712503 (freier Volltext) (Review).
  • P. A. Vöhringer, S. N. Ghaemi: Solving the antidepressant efficacy question: effect sizes in major depressive disorder. In: Clinical therapeutics. Band 33, Nummer 12, Dezember 2011, S. B49–B61, doi:10.1016/j.clinthera.2011.11.019, PMID 22136980, PMC 3242920 (freier Volltext) (Review).
  • D. Santarsieri, T. L. Schwartz: Antidepressant efficacy and side-effect burden: a quick guide for clinicians. In: Drugs in context. Band 4, 2015, S. 212290, doi:10.7573/dic.212290. PMID 26576188, PMC 4630974 (freier Volltext) (Review).
  • F. L. Rocha, C. Fuzikawa, R. Riera, C. Hara: Combination of antidepressants in the treatment of major depressive disorder: a systematic review and meta-analysis. In: Journal of clinical psychopharmacology. Band 32, Nummer 2, April 2012, S. 278–281, doi:10.1097/JCP.0b013e318248581b. PMID 22367652 (Review).
  • C. Björkholm, L. M. Monteggia: BDNF - a key transducer of antidepressant effects. In: Neuropharmacology. [elektronische Veröffentlichung vor dem Druck] November 2015, doi:10.1016/j.neuropharm.2015.10.034. PMID 26519901 (Review).
  • J. S. Lindholm, E. Castrén: Mice with altered BDNF signaling as models for mood disorders and antidepressant effects. In: Frontiers in behavioral neuroscience. Band 8, 2014, S. 143, doi:10.3389/fnbeh.2014.00143. PMID 24817844, PMC 4012208 (freier Volltext) (Review).
  • E. Castrén, T. Rantamäki: Neurotrophins in depression and antidepressant effects. In: Novartis Foundation symposium. Band 289, 2008, S. 43–52. PMID 18497094 (Review).
  • Ben Singh, Timothy Olds, Rachel Curtis, Dorothea Dumuid, Rosa Virgara, Amanda Watson, Kimberley Szeto, Edward O’Connor, Ty Ferguson, Emily Eglitis, Aaron Miatke, Catherine EM Simpson, Carol Maher: Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. In: British Journal of Sports Medicine. 16. Februar 2023, ISSN 0306-3674, doi:10.1136/bjsports-2022-106195, PMID 36796860 (bmj.com [abgerufen am 10. März 2023]).
  • A. Kandola, G. Ashdown-Franks, J. Hendrikse, C. M. Sabiston, B. Stubbs: Physical activity and depression: Towards understanding the antidepressant mechanisms of physical activity. In: Neuroscience and biobehavioral reviews. Band 107, Dezember 2019, S. 525–539, doi:10.1016/j.neubiorev.2019.09.040, PMID 31586447 (Review), PDF.
  • C. R. Sharpe, J. P. Collet, E. Belzile, J. A. Hanley, J. F. Boivin: The effects of tricyclic antidepressants on breast cancer risk. In: British Journal of Cancer. Band 86, Nummer 1, Januar 2002, S. 92–97, doi:10.1038/sj.bjc.6600013. PMID 11857018, PMC 2746543 (freier Volltext).
  • Y. Kitaichi, T. Inoue, S. Nakagawa, S. Boku, T. Izumi, T. Koyama: Combined treatment with MAO-A inhibitor and MAO-B inhibitor increases extracellular noradrenaline levels more than MAO-A inhibitor alone through increases in beta-phenylethylamine. In: Eur J Pharmacol. 637(1-3), 10. Jul 2010, S. 77 ff., doi:10.1016/j.ejphar.2010.04.014 Epub 2010 Apr 18. PMID 20406628
  • McEwen u. a.: The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. In: Molecular Psychiatry. Band 15, März 2010, S. 237–249, PMC 2902200 (freier Volltext).
  • V. Audinot, F. Mailliet u. a.: New selective ligands of human cloned melatonin MT1- und MT2 receptors. In: Naunyn Schmiedebergs Arch Pharmacol. 367, 2003, S. 553–561. PMID 12764576
  • L. San, B. Arranz: Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. In: Eur Psychiatry. 23(6), 2008, S. 396–402. PMID 18583104
  • A. C. Nugent, N. Diazgranados, P. J. Carlson, L. Ibrahim, D. A. Luckenbaugh, N. Brutsche, P. Herscovitch, W. C. Drevets, C. A. Zarate: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. In: Bipolar disorders. Band 16, Nummer 2, März 2014, S. 119–128, doi:10.1111/bdi.12118. PMID 24103187, PMC 3949142 (freier Volltext).
  • A. McGirr, M. T. Berlim, D. J. Bond, M. P. Fleck, L. N. Yatham, R. W. Lam: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. In: Psychological medicine. Band 45, Nummer 4, März 2015, S. 693–704, doi:10.1017/S0033291714001603. PMID 25010396 (Review).
  • L. Reinstatler, N. A. Youssef: Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. In: Drugs in R&D. Band 15, Nummer 1, März 2015, S. 37–43, doi:10.1007/s40268-015-0081-0. PMID 25773961, PMC 4359177 (freier Volltext) (Review).
  • D. R. Lara, L. W. Bisol, L. R. Munari: Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. In: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. Band 16, Nummer 9, Oktober 2013, S. 2111–2117, doi:10.1017/S1461145713000485. PMID 23683309.
  • C. M. Coyle, K. R. Laws: The use of ketamine as an antidepressant: a systematic review and meta-analysis. In: Human psychopharmacology. Band 30, Nummer 3, Mai 2015, S. 152–163, doi:10.1002/hup.2475. PMID 25847818 (Review).
  • T. A. Henderson: Practical application of the neuroregenerative properties of ketamine: real world treatment experience. In: Neural regeneration research. Band 11, Nummer 2, Februar 2016, S. 195–200, doi:10.4103/1673-5374.177708, PMID 27073354, PMC 4810965 (freier Volltext) (Review).
  • M. Nielsen, E. H. Hansen, P. C. Gøtzsche: What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. In: Addiction. Band 107, Nummer 5, Mai 2012, S. 900–908, doi:10.1111/j.1360-0443.2011.03686.x, PMID 21992148 (Review).
  • G. A. Fava, A. Gatti, C. Belaise, J. Guidi, E. Offidani: Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. In: Psychotherapy and psychosomatics. Band 84, Nummer 2, 2015, S. 72–81, doi:10.1159/000370338, PMID 25721705.
  • G. A. Fava, G. Benasi, M. Lucente, E. Offidani, F. Cosci, J. Guidi: Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review. In: Psychotherapy and psychosomatics. Band 87, Nummer 4, 2018, S. 195–203, doi:10.1159/000491524, PMID 30016772 (Review).
  • J. Davies, J. Read: A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? In: Addictive behaviors. [elektronische Veröffentlichung vor dem Druck] September 2018, doi:10.1016/j.addbeh.2018.08.027, PMID 30292574.
  • Yao-Chin Wang, Po-An Tai, Tahmina Nasrin Poly, Md Mohaimenul Islam, Hsuan-Chia Yang: Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies. In: Behavioural Neurology. Band 2018, 2018, doi:10.1155/2018/5315098, PMID 30123386, PMC 6079596 (freier Volltext).
  • John Moraros, Chijioke Nwankwo, Scott B. Patten, Darrell D. Mousseau: The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. In: Depression and Anxiety. Band 34, Nr. 3, März 2017, ISSN 1520-6394, S. 217–226, doi:10.1002/da.22584, PMID 28029715, PMC 5347943 (freier Volltext).
  • Yao-Chin Wang, Po-An Tai, Tahmina Nasrin Poly, Md Mohaimenul Islam, Hsuan-Chia Yang: Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies. In: Behavioural Neurology. Band 2018, 2018, doi:10.1155/2018/5315098, PMID 30123386, PMC 6079596 (freier Volltext).
  • David Healy, Joanna Le Noury, Derelie Mangin: Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases. In: The International Journal of Risk & Safety in Medicine. Band 29, Nr. 3-4, 2018, S. 125, doi:10.3233/JRS-180744, PMID 29733030, PMC 6004900 (freier Volltext).

pharmazeutische-zeitung.de

psychiatrie.de

redirecter.toolforge.org

  • apotheken-umschau.de. Archiviert vom Original am 9. Juli 2015;.

researchgate.net

  • Areeg Bala, Hoang Minh Tue Nguyen, Wayne J. G. Hellstrom: Post-SSRI Sexual Dysfunction: A Literature Review. In: Sexual Medicine Reviews. August 2017, doi:10.1016/j.sxmr.2017.07.002 (englisch, researchgate.net [PDF; 357 kB; abgerufen am 28. Januar 2022]).

sanego.de

spektrum.de

web.archive.org

  • Das erste Antidepressivum (Memento vom 10. Juni 2020 im Internet Archive).
  • Frauen und Männer reagieren unterschiedlich auf Antidepressiva. (Memento vom 29. Oktober 2007 im Internet Archive; PDF) In: ÄP Neurologie Psychiatrie. 1/2005.
  • apotheken-umschau.de. Archiviert vom Original am 9. Juli 2015;.
  • Schätzung anhand des Verordnungsreport Baden-Württemberg, 2013. (Memento vom 22. Februar 2014 im Internet Archive; PDF) ca. 424625 DDD Moclobemid und 385105 DDD Tranylcypromin im Jahr 2011 in Baden-Württemberg
  • Leitliniensynopse zum Thema „Depression“. (Memento vom 30. Januar 2012 im Internet Archive; PDF) Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG-Berichte, 2009, Nr. 34, S. 121.

zdb-katalog.de

  • Ben Singh, Timothy Olds, Rachel Curtis, Dorothea Dumuid, Rosa Virgara, Amanda Watson, Kimberley Szeto, Edward O’Connor, Ty Ferguson, Emily Eglitis, Aaron Miatke, Catherine EM Simpson, Carol Maher: Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. In: British Journal of Sports Medicine. 16. Februar 2023, ISSN 0306-3674, doi:10.1136/bjsports-2022-106195, PMID 36796860 (bmj.com [abgerufen am 10. März 2023]).
  • Roland Seifert, Lutz Hein: Ketamin zur Behandlung von Depression und Suizidalität. In: Biospektrum. Nr. 4, 2015, ISSN 0947-0867, S. 419 (biospektrum.de [PDF; 104 kB; abgerufen am 6. Mai 2023]).
  • John Moraros, Chijioke Nwankwo, Scott B. Patten, Darrell D. Mousseau: The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis. In: Depression and Anxiety. Band 34, Nr. 3, März 2017, ISSN 1520-6394, S. 217–226, doi:10.1002/da.22584, PMID 28029715, PMC 5347943 (freier Volltext).
  • P. Schweikert-Wehner: Antidepressiva und Schlafstörungen - Eine Janusköpfige Beziehung. In: Deutscher Hausärzteverband e. V. (Hrsg.): Der Hausarzt. Nr. 58; 19. mm medizin + medien Verlag e. V., 20. November 2021, ISSN 1434-8950, S. 46–48.